Sales decline 30.31% to Rs 5.31 crore
Net profit of Beryl Drugs declined 83.87% to Rs 0.05 crore in the quarter ended December 2024 as against Rs 0.31 crore during the previous quarter ended December 2023. Sales declined 30.31% to Rs 5.31 crore in the quarter ended December 2024 as against Rs 7.62 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales5.317.62 -30 OPM %10.9210.37 -PBDT0.460.68 -32 PBT0.150.37 -59 NP0.050.31 -84Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
